Both in Pharmaceuticals
NewAmsterdam Pharma Company N.V vs MBX Biosciences
Over the past year NAMS returned −42.7% and MBX returned +154.5%; their daily moves had a correlation of 0.39.
NAMS −42.7% MBX +154.5%Growth of $1, one year, split-adjusted
| Metric | NAMS | MBX |
|---|---|---|
| Price | $20.84 | $54.04 |
| Market cap | $2.49B | $2.60B |
| Today | +4.70% | −1.75% |
| 1 month | −6.4% | −5.1% |
| 6 months | −32.8% | +68.2% |
| Year to date | −40.6% | +71.3% |
| 1 year | −43.7% | +162.2% |
| Revenue growth (YoY) | −80.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1732.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 349.7× | — |
| Net cash | $633.9M | — |
| Dividend yield | — | — |
| Volatility (60d) | 52.2% | 47.8% |
| Short % of float | 16.4% | 15.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).